AzTrials
AzTrials

Rotator Cuff Tear ArthropathyNCT01778777

Safety Study of Univers® Revers Shoulder Prosthesis

A study testing Universe Reverse Prosthesis in people with Rotator Cuff Tear Arthropathy, run by Schulthess Klinik at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary safety objective is to demonstrate that severe device-related complication (Serious Adverse Device Effect = SADE) occur within 2 years after prosthesis implantation at a rate of less than 2%. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Rotator Cuff Tear Arthropathy
What is being tested?
Universe Reverse Prosthesis
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
166 participants
Where
1 siteSwitzerland
Study dates
1 Sep 2013to 15 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient aged 18 years and over
  • Patient with primary omarthrosis or secondary osteoarthritis associated with insufficiency in the centering function of the rotator cuff
  • and
  • Willing and able to give written informed consent to participate in the study including all follow-up examinations

Who cannot join

  • Previous ipsilateral shoulder arthroplasty
  • Acute shoulder trauma
  • Post-traumatic secondary osteoarthritis
  • Rheumatoid arthritis
  • General medical contraindication to surgery
  • Known hypersensitivity to the materials used
Show all 13Show fewer
  • Tumour / malignoma
  • Any disease process that would preclude accurate evaluation (e.g. neuromuscular, psychiatric or metabolic disorder)
  • Bacterial infection at the time point of operation
  • Recent history of substance abuse
  • Legal incompetence
  • Pregnancy or
  • Participation in any other medical device or medicinal product study within the previous months that could influence the results of the present study

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Schulthess Klinik

    Zurich, Canton of Zurich, 8008

Other trials in Switzerland

About this study

Official title: Safety, Function and Quality of Life in Patient With Rotator Cuff Tear Arthropathy Treated With the Univers® Revers Shoulder Prosthesis

The primary safety objective is to demonstrate that severe device-related complication (Serious Adverse Device Effect = SADE) occur within 2 years after prosthesis implantation at a rate of less than 2%. Such adverse events include (but are not limited to) revisions due to dislocation or glenoid loosening, septic arthritis and scapular fractures requiring surgical repair.

Read the detailed description

Reverse shoulder arthroplasty and its principles are still recognized today as the gold standard for treatment of degenerative arthropathy of the shoulder associated with an irreparable tear of the rotator cuff. The new Arthrex Univers® Revers Shoulder Prosthesis shows a large and narrow range of components, whether it is a stem, cup, spacer, inlay or glenosphere. Adjustment can be done in very small steps to match anatomic and biomechanic needs. The Arthrex Univers Revers Shoulder Prosthesis is the only device up to date that can be configured in two different inclination angles without any limitation in component use.

This multicentre case-series has the goal to evaluate whether patients with rotator cuff tear arthropathy benefit from the Univers® Revers shoulder prosthesis in terms of low complication risk, as well as high function and quality of life.

Being tested
Universe Reverse Prosthesis
Keywords
rotator cuff tear arthropathy, inverse prosthesis, safety, universe reverse
Medical subject headings
Rotator Cuff Tear Arthropathy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Universe Reverse ProsthesisDevice

    Implantation of an universe reverse prosthesis

Study groups in NCT01778777
Study groupRoleWhat they receive
UniverseReverseExperimentalCohort get an universe reverse prosthesis
Receives: Device: Universe Reverse Prosthesis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. SADE within 2 years po

    The primary safety objective is to demonstrate that severe device-related complication (Serious Adverse Device Effect = SADE) occur within 2 years after prosthesis implantation at a rate of less than 2%.

    Measured: 2 years po

Secondary outcomes (9)
  1. Risk of adverse events intra-operatively, and post-operatively up to 2 years follow-up

    As typically one single surgery should be sufficient to treat the patient, all secondary surgical interventions should be revisions due to a complication.

    The occurrence and time of revision surgery (implant survival) will be described by Kaplan-Meier curve.

    Measured: 2 years

  2. Prosthesis survival at 2, 5 and 10 years

    All Patients with a prosthesis revision will be documented along with the date of revision. At each follow up time point the proportion of patients with prosthesis revision will be estimated. Time to prosthesis revision will be examined by survival methods to account for censored data.

    Measured: 2, 5 and 10 years

  3. Constant (Murley) score (CS)

    The Constant (Murley) score is possibly the most commonly used tool for assessment of shoulder function. The physician asks and documents answers to QOL questions (pain and ADL, ability to work, sleep, sports and leisure) and certain clinical parameters (active ROM, abduction strength). The different scales will be summed and normalized to O=worst to 100= best. A German version is available for clinical use. Investigators are obliged to use a spring balance for the force measurements. Only one measurement per patient per assessment will be done.

    Measured: 6mo, 1, 2, 5 and 10 years

  4. The Shoulder Pain and Disability Index (SPADI)

    The Shoulder Pain and Disability Index (SPADI) is a short, self-administered questionnaire that provides an item scoring by a visual analogue scale (VAS) from 0 (no pain/no difficulty, i.e. best) to 11 (worst pain imaginable/so difficult required help, i.e. worst). Five items assess pain and 8 items disability of the arm (function). The unweighted means of the 5 pain and the 8 function items will be transformed into the scale from 0 (=worst) to 100 (=best) for both scales and are used to determine pain and function scores. The average of these two scores then gives the total SPADI score. A validated German version is available.

    Measured: 6mo, 1, 2, 5 and 10 years

  5. Short version of the Disability of the Arm, Shoulder and Hand questionnaire (QuickDASH)

    The Disability of the Arm, Shoulder and Hand questionnaire (DASH) is a comprehensive self-administered questionnaire about symptoms and functioning of the entire upper extremity. The DASH enquires about the ability to perform simple and complex activities of daily living (ADL) that are commonly performed with either one or both arms. The total score is derived from the unweighted mean of 30 items, of which at least 27 have to be answered. The QuickDASH is a more efficient version of the DASH outcome measure that appears to retain its measurement properties. It contains eleven items and is similar with regard to scores and properties to the full DASH. A validated full-length German version is available that can be used in the shortened version.

    Measured: 6mo, 1, 2, 5 and 10 years

  6. EuroQoL EQ-5D-5L

    The EQ-5D is a widely used instrument to measure and value generic health (status). It is based on a descriptive system that defines health in terms of 5 dimensions: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. The instrument is designed for self-completion, and patients also rate their overall health on the day of the interview on a 0-100 visual analogue scale (EQ-VAS).

    Measured: 6wk, 6mo, 1, 2, 5 and 10 years

  7. Patient satisfaction

    In order to obtain an overall assessment of the arthroplasty result, patients will be asked to assess their current state of health in general related to the operated shoulder joint at the follow-up compared to the state before the arthroplasty. This so-called 'transition' question has the possible answers 'much worse', 'slightly worse', 'equal', 'slightly better', and 'much better'. Patients also rate their level of satisfaction, with the help of a numeric rating scale (NRS: 0-10), in terms of how the outcome met up to their preoperative expectations of the arthroplasty. Finally, they will be asked whether - with their current knowledge of the outcome - they would again choose the operation if they found themselves in similar circumstances to those which prevailed preoperatively.

    Measured: 6wk, 6mo, 1, 2, 5 and 10 years

  8. Radiographic Parameters

    Three radiographs should be taken at each study visit: AP view in internal and external rotation and axial view. The images will be collected digitally and centralized for latter evaluation by an independent reviewer based on the radiographic assessment CRF developed by the Schulthess clinic, including the following parameters:

    • Scapular notching
    • Signs of osteolysis at the glenoid and at the stem
    • Status of tuberculum majus and minus
    • Glenoid migration
    • Glenoid component seating
    • Stem position
    • Change of relative position of components
    • Ectopic bone formation
    • Cortical bone resorption
    • Prosthesis breakage
    • Rotation failure
    • Luxation of the prosthesis
    • PE Wear of the metaglene
    • PE Dissociation

    Measured: 6mo, 1, 2, 5 and 10 years

  9. Patient active and passive range of motion (ROM) and shoulder strength

    The following active and passive range of motion parameters will be documented:

    • Abduction
    • Elevation
    • External rotation by 0°
    • External-internal rotation by 90°

    Measured: 6mo, 1, 2, 5 and 10 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2013 (estimated)
  2. Study start1 Sep 2013
  3. Primary completion1 Jun 2019
  4. Study completion15 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
166 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01778777
Sponsor's protocol ID
UniversRevers
Status last verified
May 2022
First submitted
24 Jan 2013
Last updated
18 Apr 2023
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Universe Reverse Prosthesis in people with Rotator Cuff Tear Arthropathy, run by Schulthess Klinik at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

SADE within 2 years po (time frame: 2 years po). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in